Astria Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2021-02-08: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-02-01; Total offering amount $110,010,570.
- 2015-03-31: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-03-17; Total offering amount $20,358,737.
- 2013-11-15: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2013-10-31; Total offering amount $32,433,331.
- 2013-06-27: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2013-01-18; Total offering amount $9,195,865.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2021-02-08 | Rule 506(b) | Equity | 2021-02-01 | $110,010,570 | $110,010,570 | $0 | 23 |
| 2015-03-31 | Rule 506(b) | Equity | 2015-03-17 | $20,358,737 | $12,413,736 | $7,945,001 | 20 |
| 2013-11-15 | Rule 506(b) | Equity | 2013-10-31 | $32,433,331 | $32,433,331 | $0 | 11 |
| 2013-06-27 D/A | Rule 506 | Equity | 2013-01-18 | $9,195,865 | $9,195,865 | $0 | 14 |
| 2013-02-01 | Rule 506 | Equity | 2013-01-18 | $8,749,999 | $8,749,999 | $0 | 5 |
| 2010-04-14 | Rule 506 | Equity | 2010-04-07 | $39,740,526 | $7,740,526 | $32,000,000 | 15 |